WHO President Hails Transformation of Morocco's Health Sector
The WHO chief expressed satisfaction with the Moroccan health sector's advances during a meeting with Morocco's Health Minister Amine Tehraoui in Geneva.
The high-level talks took place on Wednesday as health leaders from around the world gathered for the 78th World Health Assembly, where a landmark pandemic agreement topped the agenda.
During the pair's meeting, Tehraoui outlined Morocco's sweeping changes reshaping the North African country's healthcare sector under King Mohammed VI's leadership.
Morocco's ambitious reforms aim to tackle long-standing challenges by ensuring fair access to care, achieving universal coverage, and dramatically improving healthcare quality nationwide.
Tehraoui also revealed plans to transform Morocco into a regional powerhouse for medical manufacturing.
At the heart of this strategy is the groundbreaking 'Marbio' initiative, which seeks to break Africa's dependence on imported medicines through technology transfer and local production capacity.
Not only did the WHO chief commend Morocco's progress in the health sector, but he also pointed out its influential role on the WHO Executive Board, describing the country as a serious partner in global health security.
Tedros pledged the WHO's continued support for Morocco's healthcare revolution, with the country undergoing what represents exactly the kind of transformation the world needs to see more of.
As Morocco positions itself as a bridge between Europe, the Middle East, and the rest of Africa in addressing shared health challenges, this meeting signals the country's growing influence in regional health policy.
Morocco has transformed its healthcare with modern infrastructure and international partnerships. Maternal mortality dropped 70% over two decades, reporting a decline from 244 to 72 deaths per 100,000 births between 2000 and 2020.
The country plans to increase health professionals from 18 to 45 per 10,000 people by 2030 and boost health positions from 4,000 to 6,500 by 2025. The government is also developing a mental health strategy to serve the nearly half of Moroccans who may experience psychological disorders.
Currently, 3,230 mental health professionals are mobilized to support these individuals. Tags: Health sectorMorocco health sectorWHO Morocco
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Morocco World
5 hours ago
- Morocco World
Morocco Performs Africa's First Kidney Transplant With Different Blood Types
Rabat – The Mohammed VI Foundation for Science and Health announced on Tuesday in Casablanca that it has successfully carried out the first kidney transplant in Africa between a donor and recipient with different ABO blood types. This medical achievement was made possible through close coordination between several hospital departments, including anesthesia and intensive care, nephrology, urology, hematology, medical biology, especially immunology, the Mohammed VI Blood Transfusion Center, and a vascular surgery team. The procedure also received scientific support from Professor Lionel Rostaing , an expert in ABO-incompatible kidney transplants. Professor Abdelbar Oubaaz, Director General of a hospital under the Mohammed VI Foundation in Casablanca, said this operation is a first both in Morocco and across Africa. He explained that its success was due to the human, technical, and organizational resources available at the institution. He noted that the main challenge in such surgeries lies in preparing the patient before the transplant, which requires cooperation between experts in several medical fields, including hematology, immunology, nephrology, urology, and vascular surgery. The Moroccan medical team also received assistance from a well-known French professor to ensure the best conditions before surgery, Oubaaz added. He noted that the transplant itself was carried out entirely by Moroccan doctors. Oubaaz said the patient's condition is showing positive signs, adding that this success offers new hope to many patients who depend on dialysis. Doctor Ramdani Benyounes, head of the nephrology department at the foundation's hospitals, spoke of the strategic importance of this progress, noting that around a quarter of patients needing kidney transplants are not compatible with their donor's ABO blood type. He explained that the patient underwent a month-long preparation period, followed by intensive monitoring during the critical first weeks after the surgery. 'We are now on the sixteenth day after the transplant. The patient has normal kidney function and has completely stopped dialysis, which gives us hope that the kidney will work for many years and allow her to return to a normal life,' he concluded. Tags: AfricaHealthkidney transplant
Morocco World
a day ago
- Morocco World
Morocco's AMMPS Refutes Reports of 600 Chronic Disease Medication Shortages
Marrakech – The Moroccan Medicines and Health Products Agency (AMMPS) has firmly denied reports circulating in some media outlets claiming a shortage of over 600 medications for chronic diseases in the country. In an official statement, AMMPS stated that national data does not support these reported figures. The agency noted that if such extensive shortages were real, they would cause major disruptions to the healthcare system, something that has not been observed. The agency acknowledged that occasional supply disruptions can occur, a phenomenon seen internationally. These disruptions are primarily linked to supply chain tensions, difficulties accessing raw materials, or global market fluctuations – constraints beyond any single country's control. AMMPS mentioned that Morocco proactively implements necessary measures to minimize impacts and ensure treatment continuity for patients. Working closely with the Ministry of Health and Social Protection and other stakeholders, the agency's pharmaceutical market monitoring service continuously monitors and analyzes the national medication supply. This monitoring system aims to detect potential supply tensions early and deploy rapid, targeted corrective measures when necessary to preserve access to essential medications. The agency stated that this system has already proven effective in anticipating and proactively managing risk situations before they affect patients. As part of the national pharmaceutical sovereignty strategy, AMMPS is deploying a policy structured around three priorities: strengthening local production by increasing the proportion of medicines manufactured in Morocco to reduce import dependency; promoting competition and developing generics to limit monopoly situations; and securing the supply of vital medicines through proactive planning and diverse sourcing. A national uproar over drug prices The agency's dismissal of shortage reports likewise follows a fierce dispute over medicine costs in Morocco. Last month, social media erupted when a Facebook post went viral describing how Baraclude, an antiviral prescribed for hepatitis B, reportedly cost MAD 5,266 ($526) in Morocco, while the identical medication from the same laboratory cost only MAD 580 ($58) in Turkey and approximately MAD 1,660 ($166) in France. The price difference shocked many Moroccans. The post's author claimed he had verified with Turkish sources that this was the normal market price in Turkey, not a subsidized rate, making the price in Morocco more than nine times higher. Unions have pointed out that dozens of medications in Morocco are sold at significantly higher prices than abroad, with some costing two to five times more than in Europe. Other industry sources suggested several possible explanations for the price discrepancies, including reference prices dropping in other countries while the medication was absent from the Moroccan market, successive devaluations of the Turkish lira, and differences in healthcare systems across reference countries. The controversy centers on Morocco's medication pricing system, which uses a decree more than ten years old. This system calculates prices based on rates in reference countries (France, Spain, Belgium, Portugal, Turkey, Saudi Arabia, and the country of origin), selecting the lowest price as reference. Fixed margins for distributors and pharmacists are then applied, plus a 7% VAT. Critics call this method rigid and disconnected from public health realities, as it fails to consider citizens' purchasing power, sales volume, or medical priorities. On July 21, Health Minister Amine Tahraoui announced to the House of Representatives that a new regulatory text is in its final phase and will soon be submitted to the Government Council. This reform aims to significantly reduce prices while balancing patient accessibility with support for local production. The minister detailed that this reform was developed through over 30 meetings with industry federations, pharmacist representatives, and insurance sector officials. The new model focuses on reducing price revision timeframes, implementing changes gradually to ensure market stability, protecting low-priced medications, and encouraging domestic production. Subsequent investigations, however, revealed that Baraclude hasn't been marketed in Morocco for at least five years. The medication was previously distributed by Maphar under license from Bristol-Myers Squibb before their local office closed. The AMMPS website confirms Baraclude's withdrawal from the market in both 0.5 mg and 1 mg versions. Several pharmacists confirmed that Opavir, the only generic alternative available in Morocco, has also been out of stock for several months, raising concerns about treatment options for chronic hepatitis B patients. Tags: medicationMedication prices in morocco
Morocco World
6 days ago
- Morocco World
Moroccan Doctors Call for Hunger Strike to Support Medical Colleagues in Gaza
Rabat — Moroccan healthcare professionals will stage a hunger strike today in solidarity with medical workers in Gaza and civilian victims of the Israeli-induced starvation and genocidal war. The Moroccan Coordination of Doctors for Palestine announced the hunger strike for August 7, representing medical professionals across Morocco who want to support their Gaza counterparts and Palestinian residents suffering from catastrophic, inhumane conditions. This hunger strike forms part of a broader campaign of protests and sit-ins taking place in multiple Moroccan cities. The demonstrations aim to support Palestinians facing Israeli attacks and worsening humanitarian conditions in Gaza. The medical coordination group has made several demands through these actions. Notably, they demand that Israel end what they describe as systematic starvation policies against Palestinians. The doctors also call for an end to genocidal assaults against civilians and the opening of border crossings to allow food and medical supplies to enter Gaza. Additionally, the Moroccan medical professionals demand that Morocco end all forms of diplomatic normalization with Israel. The strike reflects a growing concern among Moroccan healthcare workers about the conditions their colleagues face in Gaza's medical facilities. Many hospitals and clinics in Gaza have suffered Israeli bombardment during the ongoing genocide, making it impossible for medical staff to provide medical care for victims. The Moroccan doctors' action represents one of several solidarity movements emerging across the Arab world as healthcare professionals express concern about the humanitarian situation in Gaza and the challenges facing medical workers there. The World Health Organization has reported that at least 94 percent of hospitals in Gaza have been damaged or destroyed, making it impossible to provide health care to victims of the genocide. Tags: gaza genocidegaza hospitalHealth care professionalsMoroccan doctors
